Cargando…
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics
BACKGROUND & AIMS: A generalized human pacemaking syndrome, chronic atrial and intestinal dysrhythmia (CAID) (OMIM 616201), is caused by a homozygous SGO1 mutation (K23E), leading to chronic intestinal pseudo-obstruction and arrhythmias. Because CAID patients do not show phenotypes consistent wi...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369230/ https://www.ncbi.nlm.nih.gov/pubmed/30739867 http://dx.doi.org/10.1016/j.jcmgh.2018.10.011 |
_version_ | 1783394143231279104 |
---|---|
author | Piché, Jessica Gosset, Natacha Legault, Lisa-Marie Pacis, Alain Oneglia, Andrea Caron, Maxime Chetaille, Philippe Barreiro, Luis Liu, Donghai Qi, Xioyan Nattel, Stanley Leclerc, Séverine Breton-Larrivée, Mélanie McGraw, Serge Andelfinger, Gregor |
author_facet | Piché, Jessica Gosset, Natacha Legault, Lisa-Marie Pacis, Alain Oneglia, Andrea Caron, Maxime Chetaille, Philippe Barreiro, Luis Liu, Donghai Qi, Xioyan Nattel, Stanley Leclerc, Séverine Breton-Larrivée, Mélanie McGraw, Serge Andelfinger, Gregor |
author_sort | Piché, Jessica |
collection | PubMed |
description | BACKGROUND & AIMS: A generalized human pacemaking syndrome, chronic atrial and intestinal dysrhythmia (CAID) (OMIM 616201), is caused by a homozygous SGO1 mutation (K23E), leading to chronic intestinal pseudo-obstruction and arrhythmias. Because CAID patients do not show phenotypes consistent with perturbation of known roles of SGO1, we hypothesized that noncanonical roles of SGO1 drive the clinical manifestations observed. METHODS: To identify a molecular signature for CAID syndrome, we achieved unbiased screens in cell lines and gut tissues from CAID patients vs wild-type controls. We performed RNA sequencing along with stable isotope labeling with amino acids in cell culture. In addition, we determined the genome-wide DNA methylation and chromatin accessibility signatures using reduced representative bisulfite sequencing and assay for transposase-accessible chromatin with high-throughput sequencing. Functional studies included patch-clamp, quantitation of transforming growth factor-β (TGF-β) signaling, and immunohistochemistry in CAID patient gut biopsy specimens. RESULTS: Proteome and transcriptome studies converge on cell-cycle regulation, cardiac conduction, and smooth muscle regulation as drivers of CAID syndrome. Specifically, the inward rectifier current, an important regulator of cellular function, was disrupted. Immunohistochemistry confirmed overexpression of Budding Uninhibited By Benzimidazoles 1 (BUB1) in patients, implicating the TGF-β pathway in CAID pathogenesis. Canonical TGF-β signaling was up-regulated and uncoupled from noncanonical signaling in CAID patients. Reduced representative bisulfite sequencing and assay for transposase-accessible chromatin with high-throughput sequencing experiments showed significant changes of chromatin states in CAID, pointing to epigenetic regulation as a possible pathologic mechanism. CONCLUSIONS: Our findings point to impaired inward rectifier potassium current, dysregulation of canonical TGF-β signaling, and epigenetic regulation as potential drivers of intestinal and cardiac manifestations of CAID syndrome. Transcript profiling and genomics data are as follows: repository URL: https://www.ncbi.nlm.nih.gov/geo; SuperSeries GSE110612 was composed of the following subseries: GSE110309, GSE110576, and GSE110601. |
format | Online Article Text |
id | pubmed-6369230 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-63692302019-02-20 Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics Piché, Jessica Gosset, Natacha Legault, Lisa-Marie Pacis, Alain Oneglia, Andrea Caron, Maxime Chetaille, Philippe Barreiro, Luis Liu, Donghai Qi, Xioyan Nattel, Stanley Leclerc, Séverine Breton-Larrivée, Mélanie McGraw, Serge Andelfinger, Gregor Cell Mol Gastroenterol Hepatol Original Research BACKGROUND & AIMS: A generalized human pacemaking syndrome, chronic atrial and intestinal dysrhythmia (CAID) (OMIM 616201), is caused by a homozygous SGO1 mutation (K23E), leading to chronic intestinal pseudo-obstruction and arrhythmias. Because CAID patients do not show phenotypes consistent with perturbation of known roles of SGO1, we hypothesized that noncanonical roles of SGO1 drive the clinical manifestations observed. METHODS: To identify a molecular signature for CAID syndrome, we achieved unbiased screens in cell lines and gut tissues from CAID patients vs wild-type controls. We performed RNA sequencing along with stable isotope labeling with amino acids in cell culture. In addition, we determined the genome-wide DNA methylation and chromatin accessibility signatures using reduced representative bisulfite sequencing and assay for transposase-accessible chromatin with high-throughput sequencing. Functional studies included patch-clamp, quantitation of transforming growth factor-β (TGF-β) signaling, and immunohistochemistry in CAID patient gut biopsy specimens. RESULTS: Proteome and transcriptome studies converge on cell-cycle regulation, cardiac conduction, and smooth muscle regulation as drivers of CAID syndrome. Specifically, the inward rectifier current, an important regulator of cellular function, was disrupted. Immunohistochemistry confirmed overexpression of Budding Uninhibited By Benzimidazoles 1 (BUB1) in patients, implicating the TGF-β pathway in CAID pathogenesis. Canonical TGF-β signaling was up-regulated and uncoupled from noncanonical signaling in CAID patients. Reduced representative bisulfite sequencing and assay for transposase-accessible chromatin with high-throughput sequencing experiments showed significant changes of chromatin states in CAID, pointing to epigenetic regulation as a possible pathologic mechanism. CONCLUSIONS: Our findings point to impaired inward rectifier potassium current, dysregulation of canonical TGF-β signaling, and epigenetic regulation as potential drivers of intestinal and cardiac manifestations of CAID syndrome. Transcript profiling and genomics data are as follows: repository URL: https://www.ncbi.nlm.nih.gov/geo; SuperSeries GSE110612 was composed of the following subseries: GSE110309, GSE110576, and GSE110601. Elsevier 2018-10-24 /pmc/articles/PMC6369230/ /pubmed/30739867 http://dx.doi.org/10.1016/j.jcmgh.2018.10.011 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Piché, Jessica Gosset, Natacha Legault, Lisa-Marie Pacis, Alain Oneglia, Andrea Caron, Maxime Chetaille, Philippe Barreiro, Luis Liu, Donghai Qi, Xioyan Nattel, Stanley Leclerc, Séverine Breton-Larrivée, Mélanie McGraw, Serge Andelfinger, Gregor Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics |
title | Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics |
title_full | Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics |
title_fullStr | Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics |
title_full_unstemmed | Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics |
title_short | Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics |
title_sort | molecular signature of caid syndrome: noncanonical roles of sgo1 in regulation of tgf-β signaling and epigenomics |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369230/ https://www.ncbi.nlm.nih.gov/pubmed/30739867 http://dx.doi.org/10.1016/j.jcmgh.2018.10.011 |
work_keys_str_mv | AT pichejessica molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT gossetnatacha molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT legaultlisamarie molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT pacisalain molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT onegliaandrea molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT caronmaxime molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT chetaillephilippe molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT barreiroluis molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT liudonghai molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT qixioyan molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT nattelstanley molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT leclercseverine molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT bretonlarriveemelanie molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT mcgrawserge molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics AT andelfingergregor molecularsignatureofcaidsyndromenoncanonicalrolesofsgo1inregulationoftgfbsignalingandepigenomics |